SARS-CoV-2 Technical Brief

Purpose

This Technical Brief is an up-to-date overview on the predicted impact, if any, to the performance of Abbott RealTime SARS-CoV-2, Alinity m
SARS-CoV-2, and Alinity m Resp-4-Plex diagnostic tests in the detection of SARS-CoV-2 viral variants, as determined through ongoing analysis by
the Abbott Pandemic Defense Coalition. This document is provided as assurance to customers that Abbott is conducting continuous and thorough
analysis of emerging SARS-CoV-2 variants.

Please click here to read the latest version.

SITE MAP

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Other trademarks are the property of their respective owners.

This Internet site that you have requested is intended for the residents of a particular country or countries and may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which this site is directed, contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.

ALL PRODUCTS

VYSIS FISH CHROMOSOME SEARCH

SOLUTIONS

EXPLORE PRODUCT CATALOG

CONTACT

WHO WE ARE

CAREERS

CORE LABORATORY

POINT OF CARE

TRANSFUSION MEDICINE

SARS-CoV-2/COVID-19 Diagnostic Tests Technical Brief